Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01491698 · ClinicalTrials.gov registry record · Phase 3

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma

A Phase 3 study of Gastric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 3
Development phase
12
Enrollment target
1
Study location

NCT01491698: Completed Phase 3 study of Gastric Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01491698 is a Phase 3 study of Gastric Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 12 participants, below the 319-participant average among 153 other Gastric Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01491698, a Phase 3 study of Gastric Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This study is being done to learn more about how different surgery procedures bring back the eating pathway after removing the stomach in patients with stomach cancer. If the surgeon has decided that some, or all, of the patient's stomach must be removed the surgeon must create a new way to allow food to travel from the mouth to the intestines. Some patients develop problems because they are missing their stomach, such as lack of hunger, bloating, cramping, and heartburn. The surgeons at Memorial Sloan-Kettering Cancer Center are conducting a study to determine if a change in surgery can help reduce these symptoms. The most common method of creating a way for food is called a "Roux-en-Y", in which one part of the intestine is connected with the end of the esophagus (the swallowing tube) in the abdomen, and another connection is made between the intestines lower down. The change in surgery involves creating a pouch from a part of the intestines to replace the stomach. This study will compare the effects, good and/or bad, of gastric pouch reconstruction with the usual reconstruction to see if the pouch makes you feel better overall. This type of surgery has been used by some surgeons for many years and is known to be safe, but it is not known if it reduces symptoms or improves nutrition compared with the usual surgery.

Primary Outcome

of recruiting patients with gastric adenocarcinoma to this randomized controlled trial (RCT). We will assess this based on the number of patients who are randomized during the pilot study.

Conditions Studied

Interventions

  • PROCEDURE Roux-en-Y pouch reconstruction (RYP)
  • PROCEDURE conventional Roux-en-Y reconstruction (RYC)

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2011-12
Est. Completion 2013-08
Phase Phase 3
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01491698 record still lists

NCT01491698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 319-participant average among 153 other Gastric Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Gastric Cancer appearing as the primary indexed condition, and to 2 interventions - of which Roux-en-Y pouch reconstruction (RYP) is the first listed.

NCT01491698 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01491698 about?

NCT01491698 is a clinical study titled "Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma". This study is being done to learn more about how different surgery procedures bring back the eating pathway after removing the stomach in patients with stomach cancer. If the surgeon has decided that some, or all, of the patient's stomach must be removed the surgeon must create a new way to allow fo...

What is the current status of trial NCT01491698?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2011-12. Estimated completion is 2013-08.

What conditions does trial NCT01491698 study?

This clinical trial studies the following conditions: Gastric Cancer.

What interventions are being tested in trial NCT01491698?

The interventions under investigation include: Roux-en-Y pouch reconstruction (RYP) (PROCEDURE), conventional Roux-en-Y reconstruction (RYC) (PROCEDURE).

Who is sponsoring clinical trial NCT01491698?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01491698 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01491698's enrollment target sits among peer trials

12 151st of 153 higher than 2 of 153 other Gastric Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01491698, the US trial registry maintained by the National Library of Medicine. NCT01491698 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.